Resmetirom

CAS 920509-32-6 10 FDA-DMF suppliersSmall Molecule

Overview

Resmetirom is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3261331).

API suppliers (10)

Suppliers of Resmetirom backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF
  • CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF
  • Cipla USA, Inc.USA1 active DMF
  • LEE PHARMA LTDIndia1 active DMF
  • METROCHEM API PRIVATE LTDIndia1 active DMF
  • SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
  • Sichuan Baili Pharmaceutical Co., Ltd.China1 active DMF
  • Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
  • TIANISH LABORATORIES PRIVATE LTDIndia1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (3 approved US products), the latest listed US patent on Resmetirom expires 4 Feb 2045 and exclusivity 14 Mar 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
2-[3,5-dichloro-4-[(6-oxo-5-propan-2-yl-1H-pyridazin-3-yl)oxy]phenyl]-3,5-dioxo-1,2,4-triazine-6-carbonitrile
Canonical SMILES
CC(C)C1=CC(=NNC1=O)OC2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C(=N3)C#N)Cl
InChIKey
FDBYIYFVSAHJLY-UHFFFAOYSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo